Q8IZI9 (IFNL3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 74.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Interferon lambda-3 Short name=IFN-lambda-3 Alternative name(s): Cytokine Zcyto22 Interleukin-28B Short name=IL-28B Interleukin-28C Short name=IL-28C | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 196 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Cytokine with immunomodulatory activity. Up-regulates MHC class I antigen expression. Displays potent antiviral activity. Also displays antitumor activity. Ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1. The ligand/receptor complex seems to signal through the Jak-STAT pathway. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium. Ref.1 Ref.2 |
| Subcellular location | |
| Induction | |
| Sequence similarities | Belongs to the lambda interferon family. |
| Sequence caution | The sequence AAN28264.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Antiviral defense |
| Cellular component | Secreted |
| Coding sequence diversity | Polymorphism |
| Domain | Signal |
| Molecular function | Cytokine |
| PTM | Disulfide bond |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | defense response to virus Inferred from electronic annotation. Source: UniProtKB-KW |
| Cellular_component | extracellular space Inferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 21 | 21 | Potential | ||||||||||||||||||||||||||||||
| Chain | 22 – 196 | 175 | Interferon lambda-3 | PRO_0000015510 | |||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||
| Disulfide bond | 37 ↔ 136 | Ref.6 | |||||||||||||||||||||||||||||||
| Disulfide bond | 71 ↔ 169 | Ref.6 | |||||||||||||||||||||||||||||||
| Disulfide bond | 188 ↔ 195 | Ref.6 | |||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||
| Natural variant | 28 | 1 | R → H. Corresponds to variant rs629976 [ dbSNP | Ensembl ]. | VAR_063419 | |||||||||||||||||||||||||||||
| Natural variant | 70 | 1 | K → R. Ref.3 Corresponds to variant rs8103142 [ dbSNP | Ensembl ]. | VAR_063420 | |||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||
| Mutagenesis | 57 | 1 | K → A: 51 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Mutagenesis | 58 | 1 | D → A: 43 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Mutagenesis | 118 | 1 | V → A: 68 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Mutagenesis | 121 | 1 | Q → A: 46 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Mutagenesis | 176 | 1 | F → A: 40 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Mutagenesis | 179 | 1 | F → A: 650 fold decrease in antiviral activity. Ref.6 | ||||||||||||||||||||||||||||||
| Sequence conflict | 108 | 1 | T → S in AAN86127. Ref.2 | ||||||||||||||||||||||||||||||
| Sequence conflict | 120 | 1 | D → G in AAQ01561. Ref.3 | ||||||||||||||||||||||||||||||
| Sequence conflict | 155 | 1 | L → P in AAQ01561. Ref.3 | ||||||||||||||||||||||||||||||
| Sequence conflict | 156 | 1 | H → Y in AAN86127. Ref.2 | ||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||
| Helix | 40 – 42 | 3 | |||||||||||||||||||||||||||||||
| Helix | 47 – 65 | 19 | |||||||||||||||||||||||||||||||
| Beta strand | 71 – 73 | 3 | |||||||||||||||||||||||||||||||
| Helix | 82 – 84 | 3 | |||||||||||||||||||||||||||||||
| Helix | 87 – 89 | 3 | |||||||||||||||||||||||||||||||
| Helix | 90 – 111 | 22 | |||||||||||||||||||||||||||||||
| Helix | 113 – 134 | 22 | |||||||||||||||||||||||||||||||
| Helix | 150 – 159 | 10 | |||||||||||||||||||||||||||||||
| Helix | 161 – 163 | 3 | |||||||||||||||||||||||||||||||
| Helix | 167 – 176 | 10 | |||||||||||||||||||||||||||||||
| Helix | 178 – 182 | 5 | |||||||||||||||||||||||||||||||
| Helix | 184 – 190 | 7 | |||||||||||||||||||||||||||||||
| Helix | 191 – 194 | 4 | |||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "IL-28, IL-29 and their class II cytokine receptor IL-28R." Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D. Klucher K.M.Nat. Immunol. 4:63-68(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INDUCTION. |
| [2] | "IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex." Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. Nat. Immunol. 4:69-77(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, INDUCTION. |
| [3] | "Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells." Li M.C., Wang H.Y., Wang H.Y., Li T., He S.H. Acta Pharmacol. Sin. 27:453-459(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANT ARG-70. Tissue: Peripheral blood leukocyte. |
| [4] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [6] | "Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family." Gad H.H., Dellgren C., Hamming O.J., Vends S., Paludan S.R., Hartmann R. J. Biol. Chem. 284:20869-20875(2009) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), DISULFIDE BONDS, MUTAGENESIS OF LYS-57; ASP-58; VAL-118; GLN-121; PHE-176 AND PHE-179. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AY129149 mRNA. Translation: AAN28264.1. Different initiation. AY184374 mRNA. Translation: AAN86127.1. AY336714 mRNA. Translation: AAR24509.1. AY336717 mRNA. Translation: AAQ01561.1. AC011445 Genomic DNA. No translation available. BC130314 mRNA. Translation: AAI30315.1. BC130316 mRNA. Translation: AAI30317.1. | ||||||||||||
| IPI | IPI00969047. | ||||||||||||
| RefSeq | NP_742151.2. NM_172139.2. | ||||||||||||
| UniGene | Hs.406744. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q8IZI9. | ||||||||||||
| SMR | Q8IZI9. Positions 37-196. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | 9606.ENSP00000347165. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 300669648. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q8IZI9. | ||||||||||||
| PRIDE | Q8IZI9. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 282617. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000413851; ENSP00000409000; ENSG00000197110. | ||||||||||||
| GeneID | 282617. | ||||||||||||
| KEGG | hsa:282617. | ||||||||||||
| UCSC | uc010xut.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 282617. | ||||||||||||
| GeneCards | GC19M039734. | ||||||||||||
| HGNC | HGNC:18365. IFNL3. | ||||||||||||
| MIM | 607402. gene. | ||||||||||||
| neXtProt | NX_Q8IZI9. | ||||||||||||
| Orphanet | 284102. Response to polyethylene glycol/interferon-ribavirin in hepatitis C virus. | ||||||||||||
| PharmGKB | PA134952671. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG40189. | ||||||||||||
| HOGENOM | HOG000232074. | ||||||||||||
| HOVERGEN | HBG052108. | ||||||||||||
| InParanoid | Q8IZI9. | ||||||||||||
| KO | K05447. | ||||||||||||
| OMA | CLEASAI. | ||||||||||||
| OrthoDB | EOG4X6C9D. | ||||||||||||
| PhylomeDB | Q8IZI9. | ||||||||||||
Gene expression databases | |||||||||||||
| CleanEx | HS_IL28B. | ||||||||||||
| Genevestigator | Q8IZI9. | ||||||||||||
| GermOnline | ENSG00000197110. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q8IZI9. | ||||||||||||
| GenomeRNAi | 282617. | ||||||||||||
| NextBio | 93470. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | IFNL3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8IZI9 Secondary accession number(s): A2BDE1 Q8IWL6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
